The Shrink Study: shrink factor of resected tumour mucosa in patients with oral squamous cell carcinoma

Completed

• Conditions: oral cancer; 10019190; oral squamous cell carcinoma; 10072990

• Registration Number: NL-OMON41703
• Lead Sponsor: niversitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 76

Inclusion Criteria

> 18 years old
Confirmed OSCC stage I - IVa
ASA classification I, II and III

Exclusion Criteria

Previously operated/irradiated in the field of surgery
Stage IVb
Physical status that is a contraindication for surgery in general anesthesia
Mental impairment ;note: In the rare case that the surgeon pre- or peroperatively finds that the randomized modality is not suitable for resection of a patients tumor, this patient will be withdrawn from the study and treated as the surgeon thinks suitable.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The amount/percentage of mucosa shrinking for the two abovementioned resection<br /><br>modalities (MO en TL), and hereby adjust margin interpretation method using<br /><br>the energy used for the electric resection modalities.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>